Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

Two new assessments of clinical trials pointed to the need for more investment in Alzheimer's disease treatments. At the 2024 American Geriatrics Society (AGS) scientific meeting, researchers ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

The scrutiny follows allegations of data manipulation and misleading claims about the drug's effectiveness, leading the Securities and Exchange Commission to charge the company, which resulted in a ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

New research from the University of Surrey has revealed that the time of day when blood is taken can significantly impact ...

“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

The time of day when blood is taken can affect the results of tests for diagnosing dementia, according to new research led by ...